Iron out for nontransfused thalassemia. (öffnet neues Fenster)

Marks PW.

Quelle‎: Blood 2012;120(5):928-9.

Indiziert‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (öffnet neues Fenster)

Iron overload in β-thalassemia intermedia: an emerging concern. (öffnet neues Fenster)

Musallam KM, Cappellini MD, Taher AT.

Quelle‎: Curr Opin Hematol 2013;20(3):187-92.

Indiziert‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (öffnet neues Fenster)

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (öffnet neues Fenster)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Quelle‎: Blood 2012;120(7):1531-2.

Indiziert‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (öffnet neues Fenster)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (öffnet neues Fenster)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Quelle‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Indiziert‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (öffnet neues Fenster)

Therapeutic roles of curcumin: lessons learned from clinical trials. (öffnet neues Fenster)

Gupta SC, Patchva S, Aggarwal BB.

Quelle‎: AAPS J 2013;15(1):195-218.

Indiziert‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (öffnet neues Fenster)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (öffnet neues Fenster)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Quelle‎: J Med Assoc Thai 2012;95(1):29-36.

Indiziert‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (öffnet neues Fenster)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (öffnet neues Fenster)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Quelle‎: Am J Hematol 2013;88(6):503-6.

Indiziert‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (öffnet neues Fenster)